©2019 Gilead Sciences, Inc. All rights reserved. UNBP4517 07/19
Cure, or sustained virologic response (SVR12), is defined as undetectable levels of HCV in the blood at 12 weeks after completion of therapy.1,2
You play a vital role in bringing Hep C patients closer to cure. Refer patients who have tested positive for HCV RNA to a treating provider for an evaluation—regardless of their viral load.1,3
Treatment has been shown to be more effective at early-stage disease.1,4
Inform and educate your patients that Hep C often progresses without symptoms and that initiating treatment at the earlier stage of disease may augment the benefits of cure.
Ensure the best possible care for your Hep C patients by making quality referrals and following up.
24-57% OF HEP C PATIENTS MISS THEIR FIRST APPOINTMENT WITH A TREATMENT PROVIDER.5